Navigation Links
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023
Date:8/7/2014

aracteristics over time-tested clinical mainstays, will help sustain these companies' respective franchises and earn blockbuster sales during the forecast period.
  • Ocrelizumab's clinical and commercial promise: Interviewed experts express positive opinions about ocrelizumab's potential for strong efficacy in MS as well as its relatively favorable delivery profile. Interviewed thought leaders are quick to note that the drug's safety must be established in ongoing Phase III studies, but they are cautiously optimistic that ocrelizumab may become a preferred agent in later-line MS treatment.
  • Comments from Decision Resources Group Analyst John Crowley, Ph.D.:

    • "Continued clinical success with anti-inflammatory compounds accentuates the unmet need for bona fide neuroprotective or regenerative therapies for MS. Such an agent could be initiated early in the disease process and/or in combination with immunological agents to benefit the entire spectrum of MS patients. Development in this arena is active—notably with Biogen Idec's Phase II candidate BIIB-033—but advancement overall is constrained by the difficulty of identifying valid drug targets and the optimal design for clinical trials."
    • "Interviewed experts routinely note the pressing unmet need for effective therapies to treat progressive forms of MS. Although experts generally report low expectations for ongoing clinical trials assessing drugs like Tysabri, Gilenya and ocrelizumab, the commercial potential for a successful agent is sizable—we expect a drug's approval for secondary- or primary-progressive MS could result in sales exceeding $1 billion in that population alone."

    About Decision Resources Group
    Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely o
    '/>"/>

    SOURCE Decision Resources Group
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Z Trim Launches Food-Grade Biofiber Gum
    2. OSTAR Launches Its A Series Cloud Based Telehealth Vital Signs Patient Monitoring System
    3. SOLS Systems Announces Nationwide Launch Of 3D Printed Orthotics
    4. Janssen Launches Online Healthy Minds Video Series
    5. AARC Launches Virtual Museum
    6. InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
    7. Drew Crawford Announces Launch of PBM365 Media
    8. CPhI South America 2014 Launches with Generics Showing Huge Growth
    9. Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
    10. MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe
    11. UBM Medica US Launches NeurologyTimes.com
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
    (Date:7/31/2015)... , July 31, 2015 According ... Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry ... Weighing) - Global Analysis & Forecast to 2019", published ... pegged at $911.1 Million 2014 and is estimated to ... CAGR of 9.4% from 2014 to 2019. ...
    (Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO.  "Bob has provided a valuable perspective ...
    Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
    ... , WOODCLIFF LAKE, N.J. , May 10 ... today announced that its partner, Glenmark Generics Limited and Glenmark ... agreement with Merck & Co. Inc. that resolves patent litigation ... This settlement effectively ends the lawsuit involving a challenge by ...
    ... BEIJING , May 10 ... nearly,two-year trial, the ten arbitration cases with Beijing Un-Assegai Technical ... distributor,of clinical diagnostic products in China , as claimant ... as respondent have been decided by the,China International Economic and ...
    Cached Medicine Technology:Par's Development and Marketing Partner, Glenmark, Enters Into A Settlement Agreement With Merck To Settle Patent Litigation Over Generic ZETIA(R) 2Assegai Wins Big Settlement Against ABBOTT's Subsidiary 2
    (Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it ... Bronx campus. The goal is to bring this Torah – dating from 1880 – ... rituals and religious services. , Scroll No. 515, from the town of Taus-Domazlice, ...
    (Date:8/1/2015)... ... , ... On Tuesday, July 28th, Symantec released a security industry whitepaper ... the attack on Anthem Inc. which resulted in one of the largest data breaches ... spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO of ...
    (Date:8/1/2015)... ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive ... the Appalachian Trail by stepping off Springer Mountain and heading north. Since that ... 26th Phil reached Connecticut and was greeted by friends and family. He visited CCAR ...
    (Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma ... the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key ... meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of ...
    (Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
    Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
    ... Healthy Kitchen, Healthy Lives engages a variety of health ... at The Culinary Institute of America , Greystone ... education conference that fosters a connection between nutrition science, ... Wellness Council is a participant in the event which ...
    ... Autism Awareness Day VILLANOVA, Pa. and 15 Centers Nationwide, April ... the likelihood of an autism diagnosis is four times that of ... than with cancer, diabetes and AIDS combined, yet startlingly, many parents ... in their children or where to turn for help when those ...
    ... April 1 Medicare beneficiaries who need physical ... efficient to obtain treatment under legislation introduced yesterday ... Patient Access to Physical Therapists Act (HR 1829), ... (R-PA), and Tammy Baldwin (D-WI), eliminates the need ...
    ... 2009 (BRONX, NY) Scientists at Albert Einstein College ... theory of autism that suggests that the brains of people ... the disorder might be reversible. , The central ... Brain Research Reviews , is that autism is a ...
    ... Sutter Health network of doctors, hospitals and other health ... health care quality according to the respected Lewin Group, ... The Lewin Group produces rankings of America,s 120 largest ... satisfaction data from 2007, as reported by the Centers ...
    ... April 1 Edifecs announced ... implementation issues that providers, payers, clearinghouses and other healthcare ... new standards. In these sessions, Edifecs will offer ... Edifecs5010(TM) Migration -- a comprehensive set of products, online ...
    Cached Medicine News:Health News:Tomato Products Wellness Council Joins Harvard Medical School and the Culinary Institute of America to Take Part in Healthy Kitchen, Healthy Lives April 2-5, 2009 2Health News:Tomato Products Wellness Council Joins Harvard Medical School and the Culinary Institute of America to Take Part in Healthy Kitchen, Healthy Lives April 2-5, 2009 3Health News:National Experts Offer Practical Tips for Parents Concerned about Autism 2Health News:National Experts Offer Practical Tips for Parents Concerned about Autism 3Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 3Health News:Einstein scientists propose new theory of autism 2Health News:Einstein scientists propose new theory of autism 3Health News:Sutter Health Ranks Tops in California for Quality Health Care 2Health News:Edifecs Launches First of a Series of Edifecs5010(TM) Migration Educational Webinars Addressing 5010 Migration Challenges, Opportunities and Solutions 2Health News:Edifecs Launches First of a Series of Edifecs5010(TM) Migration Educational Webinars Addressing 5010 Migration Challenges, Opportunities and Solutions 3
    ... levels of nutrients found to ... health in the AREDS clinical ... Eye Institute. MacularProtect also delivers ... antioxidant found to play an ...
    Oculair (re-formulated Syntrx Complete) is a potent full-spectrum multiple vitamin/mineral/antioxidant dietary supplement that supports the normal aging process. It is designed to reflect the most re...
    Ocuvite® Lutein is an advanced antioxidant supplement formulated to provide nutritional support for the eye....
    Expert QC data management solution...
    Medicine Products: